Dr. wenming Wei | Immunology and Microbiology | Best Researcher Award
Associate Researcher at Berijing Institue of Bilogical Products Co.,LTD；China National Biotec Group；Sinopharm, China
Dr. Wenming Wei is a dedicated biomedical scientist specializing in viral and bacterial vaccine research. With over a decade of experience in vaccine development, immunology, and virology, he has made significant contributions to the field. His expertise spans pre-clinical and clinical vaccine studies, large-scale commercial production, and quality assurance. Currently serving as a Senior Scientist and Project Manager at Beijing Institute of Biological Product Co., Ltd., Dr. Wei is a leader in novel vaccine development and regulatory compliance.
Profile
Education 🎓
Dr. Wei’s academic journey is a testament to his commitment to scientific advancement. He obtained his Bachelor of Science in Biological Technology from Xinxiang Medical University (2007–2011), followed by a Master’s degree in Pathogen Biology from the National Vaccine and Serum Institute of China (2011–2014). His PhD research at the Genome Integrity Immunity and Cancer Unit at Institut Pasteur, University of Paris (2017–2020), focused on characterizing novel DNA double-strand break repair factors in B lymphocytes. His findings were published in prestigious journals such as Nature Communications and Nature Cell Biology.
Experience 🏢
Dr. Wei has held various pivotal roles in the biomedical industry. Currently, as a Project Manager at Beijing Institute of Biological Product Co., Ltd., he leads vaccine formulation development, studies immune interactions in animal models, and pioneers research on detoxification processes for acellular pertussis vaccines. Previously, he served as Assistant QA Manager at the same institute (2020–2022), where he developed quality management systems aligning with EU-GMP and ICH guidelines. His earlier roles as a QA Specialist at Beijing Tian Tan Biological Product Co., Ltd. (2014–2017) and as a PhD researcher at Institut Pasteur enriched his expertise in vaccine validation and molecular immunology.
Research Interests 🔬
Dr. Wei’s research revolves around vaccine development, immunology, and molecular biology. He is particularly interested in:
- The development of novel combination vaccines, including DTacP-based formulations.
- The characterization of detoxification processes in acellular pertussis vaccines.
- The immunogenicity and safety evaluation of vaccine candidates in animal models.
- The role of DNA double-strand break repair proteins in immune system functions. His research aims to improve vaccine efficacy and ensure global health security.
Awards & Recognitions 🏅
Dr. Wei’s contributions to vaccine development and molecular immunology have earned him recognition in the scientific community. His groundbreaking research on double-strand break repair factors in B lymphocytes was published in Nature Communications and Nature Cell Biology, reinforcing his impact in immunological studies. Additionally, his role in advancing pertussis vaccine formulations has positioned him as a key figure in vaccine innovation.
Publications 📚
Dr. Wei’s research findings are well-documented in high-impact journals. Some of his notable publications include:
“Development and Implementation of a Single Radial Diffusion Technique for Quality Control of Acellular Pertussis Vaccines”
- Authors: Chongyang Wu, Xi Wang, Yu Zhou, Xinshuo Zhu, Yu Ma, Wenming Wei, Yuntao Zhang
- Journal: Vaccines
- Publication Year: 2025
- DOI: 10.3390/vaccines13020116
“SHLD1 is Dispensable for 53BP1-Dependent V(D)J Recombination but Critical for Productive Class Switch Recombination”
- Authors: Chloé Lescale, Ludovic Deriano, et al.
- Journal: Nature Communications
- Publication Year: 2022
- DOI: 10.1038/s41467-022-31287-3
“Shieldin Complex Promotes DNA End-Joining and Counters Homologous Recombination in BRCA1-Null Cells”
- Authors: Harsha Dev, Tzu-Wen Wang Chiang, Chloé Lescale, et al.
- Journal: Nature Cell Biology
- Publication Year: 2018
- DOI: 10.1038/s41556-018-0140-1
Conclusion 🌍
Dr. Wenming Wei is a highly qualified and accomplished researcher with significant contributions to vaccine development and biomedical sciences. His extensive experience in research, leadership in quality assurance, and academic achievements make him a strong candidate for the Best Researcher Award. Addressing areas like interdisciplinary collaborations and public engagement could further enhance his candidacy.